Login / Signup

Effectiveness and safety of risankizumab in VEry severe plaque psoriasis: a real-life retrospective study (VESPA-Study).

Diego OrsiniChiara AssorgiClaudio BonifatiNorma CameliDario GraceffaLuca PotestioMatteo Megna
Published in: The Journal of dermatological treatment (2024)
Risankizumab showed to be effective and safe in patients affected by very severe forms of psoriasis with the involvement of difficult-to-treat areas.
Keyphrases
  • end stage renal disease
  • newly diagnosed
  • ejection fraction
  • early onset
  • peritoneal dialysis
  • prognostic factors
  • hidradenitis suppurativa